ARTICLE | Clinical News
CARN 700: Began Phase I trials
January 2, 1996 8:00 AM UTC
Carrington Laboratories Inc. (CARN), Irving, Texas Product: CARN 700, complex polysaccharide for injection Indication: Various cancers, including breast, prostate, colon, soft tissue sarcoma, melanoma...